SCHEMBL20152409

SCHEMBL20152409

c1ccc(C2(c3ccccc3)c3ccccc3N(c3ccc(-c4ccc(N5c6ccccc6[Si](c6ccccc6)(c6ccccc6)c6ccccc65)cc4)cc3)c3ccccc32)cc1

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.31
MGLL Q99685 1/20 0.31
PDE6D O43924 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20383364 0.97 ADAMTS5 (0.30)
SCHEMBL20383357 0.97 ADAMTS5 (0.30)
SCHEMBL20152419 0.94 PDE6D (0.32) FAAHMGLLPDE6D
SCHEMBL20383360 0.93 ALDH1A1 (0.32)
SCHEMBL20383363 0.93 ALDH1A1 (0.32)
SCHEMBL20152415 0.92 FAAH (0.35) FAAHMGLLPDE6D
SCHEMBL20152413 0.92 FAAH (0.35) FAAHMGLLPDE6D
SCHEMBL20152395 0.88 ITGB2 (0.30)
SCHEMBL20383378 0.87 ALDH1A1 (0.30)
SCHEMBL20383367 0.87

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10673000-B2 Heterocyclic compound and organic electroluminescence device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-06-02 US disclosed
US-20180138429-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-05-17 US disclosed
US-20180138429-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180138429-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME ODC1, KCNC1, KCNH1 FAAH 1043/4885MGLL 3917/4885PDE6D 3390/4885
US-10673000-B2 Heterocyclic compound and organic electroluminescence device including the same ODC1, KCNC1, KCNH1 FAAH 1043/4885MGLL 3917/4885PDE6D 3390/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.